首页> 外文期刊>Experimental and clinical transplantation >Four-Way Kidney Exchange Transplant With Desensitization Increases Access to Living-Donor Kidney Transplant: First Report From India
【24h】

Four-Way Kidney Exchange Transplant With Desensitization Increases Access to Living-Donor Kidney Transplant: First Report From India

机译:具有脱敏作用的四向肾脏交换移植增加了活体捐赠者肾脏移植的机会:印度的第一份报告

获取原文
           

摘要

Objectives: This study reports our experience of the first 4-way kidney exchange transplant combined with desensitization in India, which allows increased access to living-donor kidney transplant for sensitized patients. Materials and Methods: Four-way kidney exchange transplant procedures were approved by the ethics committee of our institution and the Organ Transplantation Authorization Committee of state governments of India (as per the Transplantation of Human Organs Act of India). The protocols conformed to Declaration of Istanbul principles and the ethical guidelines of the 1975 Helsinki Declaration. Written informed consent was obtained from patients, donors, and their guardians. Results: In April 2016, our transplant team completed simultaneous 4-way kidney exchange transplant pro-cedures without any medical (rejection and infections) or surgical complications. Reasons for being included for kidney exchange transplant were ABO incom-patible (2 recipients) and sensitization (2 recipients). All 4 recipients had stable graft function with no proteinuria and donor-specific antibody at 11-month follow-up on standard triple immunosup-pression. Patient and graft survival rates were both 100%. Conclusions: To the best of our knowledge, this is the first single-center report of 4-way kidney exchange transplant combined with desensitization from India. This procedure has the potential to expand living-donor kidney transplant in disadvantaged groups (eg, sensitized patients). Recipients who are hard to match due to high panel reactive antibody and difficult to desensitize due to strong donor-specific antibodies can receive a transplant with a combination of kidney exchange and desensitization. Our study suggests that 4-way kidney exchange transplant can be performed in developing countries (India) similar to that shown in programs in developed countries with team work, kidney exchange registry, and counseling.
机译:目的:这项研究报告了我们在印度进行的首例四向肾脏交换移植与脱敏联合治疗的经验,这使致敏患者能够更多地使用活体供体肾移植。材料和方法:四通肾脏交换移植程序已获得本机构伦理委员会和印度州政府器官移植授权委员会的批准(根据印度《人体器官移植法》)。协议符合《伊斯坦布尔宣言》原则和1975年《赫尔辛基宣言》的道德准则。从患者,捐赠者及其监护人那里获得了书面知情同意书。结果:2016年4月,我们的移植团队完成了同时进行的4路肾脏交换移植程序,没有任何医疗(排斥和感染)或手术并发症。被纳入肾脏交换移植的原因是ABO不兼容(2位接受者)和致敏性(2位接受者)。在标准三重免疫抑制的11个月随访中,所有4位受体的移植功能均稳定,无蛋白尿和供体特异性抗体。患者和移植物的存活率均为100%。结论:据我们所知,这是印度进行的四向肾脏交换移植联合脱敏的首个单中心报告。这种方法有可能扩大弱势群体(例如致敏患者)的活体供肾肾移植。由于高面板反应性抗体而难以匹配且由于强的供体特异性抗体而难以脱敏的接受者可以接受肾脏置换和脱敏的组合移植。我们的研究表明,可以在发展中国家(印度)进行四路肾脏交换移植,这与发达国家在团队合作,肾脏交换注册和咨询方面的计划相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号